1 Market Overview

1.1 Product Overview and Scope of Rare Disease Genetic Testing

1.2 Classification of Rare Disease Genetic Testing by Type

1.2.1 Overview: Global Rare Disease Genetic Testing Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Rare Disease Genetic Testing Revenue Market Share by Type in 2021

1.2.3 Next-Generation Sequencing (NGS)

1.2.4 Array Technology

1.2.5 PCR-based Testing

1.2.6 Fluorescence in Situ Hybridization (FISH)

1.2.7 Sanger Sequencing

1.2.8 Karyotyping

1.2.9 Others

1.3 Global Rare Disease Genetic Testing Market by Application

1.3.1 Overview: Global Rare Disease Genetic Testing Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Research Laboratories and CROs

1.3.3 Diagnostic Laboratories

1.3.4 Hospitals and Clinics

1.3.5 Others

1.4 Global Rare Disease Genetic Testing Market Size & Forecast

1.5 Global Rare Disease Genetic Testing Market Size and Forecast by Region

1.5.1 Global Rare Disease Genetic Testing Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Rare Disease Genetic Testing Market Size by Region, (2017-2022)

1.5.3 North America Rare Disease Genetic Testing Market Size and Prospect (2017-2028)

1.5.4 Europe Rare Disease Genetic Testing Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Rare Disease Genetic Testing Market Size and Prospect (2017-2028)

1.5.6 South America Rare Disease Genetic Testing Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Rare Disease Genetic Testing Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Rare Disease Genetic Testing Market Drivers

1.6.2 Rare Disease Genetic Testing Market Restraints

1.6.3 Rare Disease Genetic Testing Trends Analysis

2 Company Profiles

2.1 Quest Diagnostics

2.1.1 Quest Diagnostics Details

2.1.2 Quest Diagnostics Major Business

2.1.3 Quest Diagnostics Rare Disease Genetic Testing Product and Solutions

2.1.4 Quest Diagnostics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Quest Diagnostics Recent Developments and Future Plans

2.2 Centogene

2.2.1 Centogene Details

2.2.2 Centogene Major Business

2.2.3 Centogene Rare Disease Genetic Testing Product and Solutions

2.2.4 Centogene Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Centogene Recent Developments and Future Plans

2.3 Invitae Corporation

2.3.1 Invitae Corporation Details

2.3.2 Invitae Corporation Major Business

2.3.3 Invitae Corporation Rare Disease Genetic Testing Product and Solutions

2.3.4 Invitae Corporation Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Invitae Corporation Recent Developments and Future Plans

2.4 3billion

2.4.1 3billion Details

2.4.2 3billion Major Business

2.4.3 3billion Rare Disease Genetic Testing Product and Solutions

2.4.4 3billion Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 3billion Recent Developments and Future Plans

2.5 Arup Laboratories

2.5.1 Arup Laboratories Details

2.5.2 Arup Laboratories Major Business

2.5.3 Arup Laboratories Rare Disease Genetic Testing Product and Solutions

2.5.4 Arup Laboratories Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Arup Laboratories Recent Developments and Future Plans

2.6 Eurofins Scientific

2.6.1 Eurofins Scientific Details

2.6.2 Eurofins Scientific Major Business

2.6.3 Eurofins Scientific Rare Disease Genetic Testing Product and Solutions

2.6.4 Eurofins Scientific Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Eurofins Scientific Recent Developments and Future Plans

2.7 Strand Life Sciences

2.7.1 Strand Life Sciences Details

2.7.2 Strand Life Sciences Major Business

2.7.3 Strand Life Sciences Rare Disease Genetic Testing Product and Solutions

2.7.4 Strand Life Sciences Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Strand Life Sciences Recent Developments and Future Plans

2.8 Ambry Genetics

2.8.1 Ambry Genetics Details

2.8.2 Ambry Genetics Major Business

2.8.3 Ambry Genetics Rare Disease Genetic Testing Product and Solutions

2.8.4 Ambry Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Ambry Genetics Recent Developments and Future Plans

2.9 Perkin Elmer

2.9.1 Perkin Elmer Details

2.9.2 Perkin Elmer Major Business

2.9.3 Perkin Elmer Rare Disease Genetic Testing Product and Solutions

2.9.4 Perkin Elmer Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Perkin Elmer Recent Developments and Future Plans

2.10 Macrogen

2.10.1 Macrogen Details

2.10.2 Macrogen Major Business

2.10.3 Macrogen Rare Disease Genetic Testing Product and Solutions

2.10.4 Macrogen Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Macrogen Recent Developments and Future Plans

2.11 Baylor Genetics

2.11.1 Baylor Genetics Details

2.11.2 Baylor Genetics Major Business

2.11.3 Baylor Genetics Rare Disease Genetic Testing Product and Solutions

2.11.4 Baylor Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Baylor Genetics Recent Developments and Future Plans

2.12 Color Genomics

2.12.1 Color Genomics Details

2.12.2 Color Genomics Major Business

2.12.3 Color Genomics Rare Disease Genetic Testing Product and Solutions

2.12.4 Color Genomics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Color Genomics Recent Developments and Future Plans

2.13 Preventiongenetics

2.13.1 Preventiongenetics Details

2.13.2 Preventiongenetics Major Business

2.13.3 Preventiongenetics Rare Disease Genetic Testing Product and Solutions

2.13.4 Preventiongenetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Preventiongenetics Recent Developments and Future Plans

2.14 Progenity

2.14.1 Progenity Details

2.14.2 Progenity Major Business

2.14.3 Progenity Rare Disease Genetic Testing Product and Solutions

2.14.4 Progenity Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Progenity Recent Developments and Future Plans

2.15 Coopersurgical

2.15.1 Coopersurgical Details

2.15.2 Coopersurgical Major Business

2.15.3 Coopersurgical Rare Disease Genetic Testing Product and Solutions

2.15.4 Coopersurgical Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Coopersurgical Recent Developments and Future Plans

2.16 Fulgent Genetics

2.16.1 Fulgent Genetics Details

2.16.2 Fulgent Genetics Major Business

2.16.3 Fulgent Genetics Rare Disease Genetic Testing Product and Solutions

2.16.4 Fulgent Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Fulgent Genetics Recent Developments and Future Plans

2.17 Myriad Genetics

2.17.1 Myriad Genetics Details

2.17.2 Myriad Genetics Major Business

2.17.3 Myriad Genetics Rare Disease Genetic Testing Product and Solutions

2.17.4 Myriad Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Myriad Genetics Recent Developments and Future Plans

2.18 LabCorp

2.18.1 LabCorp Details

2.18.2 LabCorp Major Business

2.18.3 LabCorp Rare Disease Genetic Testing Product and Solutions

2.18.4 LabCorp Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 LabCorp Recent Developments and Future Plans

2.19 Opko Health

2.19.1 Opko Health Details

2.19.2 Opko Health Major Business

2.19.3 Opko Health Rare Disease Genetic Testing Product and Solutions

2.19.4 Opko Health Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 Opko Health Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Rare Disease Genetic Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Rare Disease Genetic Testing Players Market Share in 2021

3.2.2 Top 10 Rare Disease Genetic Testing Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Rare Disease Genetic Testing Players Head Office, Products and Services Provided

3.4 Rare Disease Genetic Testing Mergers & Acquisitions

3.5 Rare Disease Genetic Testing New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Rare Disease Genetic Testing Revenue and Market Share by Type (2017-2022)

4.2 Global Rare Disease Genetic Testing Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Rare Disease Genetic Testing Revenue Market Share by Application (2017-2022)

5.2 Global Rare Disease Genetic Testing Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Rare Disease Genetic Testing Revenue by Type (2017-2028)

6.2 North America Rare Disease Genetic Testing Revenue by Application (2017-2028)

6.3 North America Rare Disease Genetic Testing Market Size by Country

6.3.1 North America Rare Disease Genetic Testing Revenue by Country (2017-2028)

6.3.2 United States Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

6.3.3 Canada Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

6.3.4 Mexico Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Rare Disease Genetic Testing Revenue by Type (2017-2028)

7.2 Europe Rare Disease Genetic Testing Revenue by Application (2017-2028)

7.3 Europe Rare Disease Genetic Testing Market Size by Country

7.3.1 Europe Rare Disease Genetic Testing Revenue by Country (2017-2028)

7.3.2 Germany Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

7.3.3 France Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

7.3.5 Russia Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

7.3.6 Italy Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Rare Disease Genetic Testing Revenue by Type (2017-2028)

8.2 Asia-Pacific Rare Disease Genetic Testing Revenue by Application (2017-2028)

8.3 Asia-Pacific Rare Disease Genetic Testing Market Size by Region

8.3.1 Asia-Pacific Rare Disease Genetic Testing Revenue by Region (2017-2028)

8.3.2 China Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

8.3.3 Japan Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

8.3.4 South Korea Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

8.3.5 India Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

8.3.7 Australia Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Rare Disease Genetic Testing Revenue by Type (2017-2028)

9.2 South America Rare Disease Genetic Testing Revenue by Application (2017-2028)

9.3 South America Rare Disease Genetic Testing Market Size by Country

9.3.1 South America Rare Disease Genetic Testing Revenue by Country (2017-2028)

9.3.2 Brazil Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

9.3.3 Argentina Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Rare Disease Genetic Testing Revenue by Type (2017-2028)

10.2 Middle East & Africa Rare Disease Genetic Testing Revenue by Application (2017-2028)

10.3 Middle East & Africa Rare Disease Genetic Testing Market Size by Country

10.3.1 Middle East & Africa Rare Disease Genetic Testing Revenue by Country (2017-2028)

10.3.2 Turkey Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

10.3.4 UAE Rare Disease Genetic Testing Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Rare Disease Genetic Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Rare Disease Genetic Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Rare Disease Genetic Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Rare Disease Genetic Testing Revenue (USD Million) by Region (2017-2022)

Table 5. Global Rare Disease Genetic Testing Revenue Market Share by Region (2023-2028)

Table 6. Quest Diagnostics Corporate Information, Head Office, and Major Competitors

Table 7. Quest Diagnostics Major Business

Table 8. Quest Diagnostics Rare Disease Genetic Testing Product and Solutions

Table 9. Quest Diagnostics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Centogene Corporate Information, Head Office, and Major Competitors

Table 11. Centogene Major Business

Table 12. Centogene Rare Disease Genetic Testing Product and Solutions

Table 13. Centogene Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Invitae Corporation Corporate Information, Head Office, and Major Competitors

Table 15. Invitae Corporation Major Business

Table 16. Invitae Corporation Rare Disease Genetic Testing Product and Solutions

Table 17. Invitae Corporation Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. 3billion Corporate Information, Head Office, and Major Competitors

Table 19. 3billion Major Business

Table 20. 3billion Rare Disease Genetic Testing Product and Solutions

Table 21. 3billion Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Arup Laboratories Corporate Information, Head Office, and Major Competitors

Table 23. Arup Laboratories Major Business

Table 24. Arup Laboratories Rare Disease Genetic Testing Product and Solutions

Table 25. Arup Laboratories Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Eurofins Scientific Corporate Information, Head Office, and Major Competitors

Table 27. Eurofins Scientific Major Business

Table 28. Eurofins Scientific Rare Disease Genetic Testing Product and Solutions

Table 29. Eurofins Scientific Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Strand Life Sciences Corporate Information, Head Office, and Major Competitors

Table 31. Strand Life Sciences Major Business

Table 32. Strand Life Sciences Rare Disease Genetic Testing Product and Solutions

Table 33. Strand Life Sciences Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Ambry Genetics Corporate Information, Head Office, and Major Competitors

Table 35. Ambry Genetics Major Business

Table 36. Ambry Genetics Rare Disease Genetic Testing Product and Solutions

Table 37. Ambry Genetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Perkin Elmer Corporate Information, Head Office, and Major Competitors

Table 39. Perkin Elmer Major Business

Table 40. Perkin Elmer Rare Disease Genetic Testing Product and Solutions

Table 41. Perkin Elmer Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Macrogen Corporate Information, Head Office, and Major Competitors

Table 43. Macrogen Major Business

Table 44. Macrogen Rare Disease Genetic Testing Product and Solutions

Table 45. Macrogen Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Baylor Genetics Corporate Information, Head Office, and Major Competitors

Table 47. Baylor Genetics Major Business

Table 48. Baylor Genetics Rare Disease Genetic Testing Product and Solutions

Table 49. Baylor Genetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Color Genomics Corporate Information, Head Office, and Major Competitors

Table 51. Color Genomics Major Business

Table 52. Color Genomics Rare Disease Genetic Testing Product and Solutions

Table 53. Color Genomics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Preventiongenetics Corporate Information, Head Office, and Major Competitors

Table 55. Preventiongenetics Major Business

Table 56. Preventiongenetics Rare Disease Genetic Testing Product and Solutions

Table 57. Preventiongenetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Progenity Corporate Information, Head Office, and Major Competitors

Table 59. Progenity Major Business

Table 60. Progenity Rare Disease Genetic Testing Product and Solutions

Table 61. Progenity Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Coopersurgical Corporate Information, Head Office, and Major Competitors

Table 63. Coopersurgical Major Business

Table 64. Coopersurgical Rare Disease Genetic Testing Product and Solutions

Table 65. Coopersurgical Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Fulgent Genetics Corporate Information, Head Office, and Major Competitors

Table 67. Fulgent Genetics Major Business

Table 68. Fulgent Genetics Rare Disease Genetic Testing Product and Solutions

Table 69. Fulgent Genetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Myriad Genetics Corporate Information, Head Office, and Major Competitors

Table 71. Myriad Genetics Major Business

Table 72. Myriad Genetics Rare Disease Genetic Testing Product and Solutions

Table 73. Myriad Genetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. LabCorp Corporate Information, Head Office, and Major Competitors

Table 75. LabCorp Major Business

Table 76. LabCorp Rare Disease Genetic Testing Product and Solutions

Table 77. LabCorp Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Opko Health Corporate Information, Head Office, and Major Competitors

Table 79. Opko Health Major Business

Table 80. Opko Health Rare Disease Genetic Testing Product and Solutions

Table 81. Opko Health Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Global Rare Disease Genetic Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 83. Global Rare Disease Genetic Testing Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 84. Breakdown of Rare Disease Genetic Testing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 85. Rare Disease Genetic Testing Players Head Office, Products and Services Provided

Table 86. Rare Disease Genetic Testing Mergers & Acquisitions in the Past Five Years

Table 87. Rare Disease Genetic Testing New Entrants and Expansion Plans

Table 88. Global Rare Disease Genetic Testing Revenue (USD Million) by Type (2017-2022)

Table 89. Global Rare Disease Genetic Testing Revenue Share by Type (2017-2022)

Table 90. Global Rare Disease Genetic Testing Revenue Forecast by Type (2023-2028)

Table 91. Global Rare Disease Genetic Testing Revenue by Application (2017-2022)

Table 92. Global Rare Disease Genetic Testing Revenue Forecast by Application (2023-2028)

Table 93. North America Rare Disease Genetic Testing Revenue by Type (2017-2022) & (USD Million)

Table 94. North America Rare Disease Genetic Testing Revenue by Type (2023-2028) & (USD Million)

Table 95. North America Rare Disease Genetic Testing Revenue by Application (2017-2022) & (USD Million)

Table 96. North America Rare Disease Genetic Testing Revenue by Application (2023-2028) & (USD Million)

Table 97. North America Rare Disease Genetic Testing Revenue by Country (2017-2022) & (USD Million)

Table 98. North America Rare Disease Genetic Testing Revenue by Country (2023-2028) & (USD Million)

Table 99. Europe Rare Disease Genetic Testing Revenue by Type (2017-2022) & (USD Million)

Table 100. Europe Rare Disease Genetic Testing Revenue by Type (2023-2028) & (USD Million)

Table 101. Europe Rare Disease Genetic Testing Revenue by Application (2017-2022) & (USD Million)

Table 102. Europe Rare Disease Genetic Testing Revenue by Application (2023-2028) & (USD Million)

Table 103. Europe Rare Disease Genetic Testing Revenue by Country (2017-2022) & (USD Million)

Table 104. Europe Rare Disease Genetic Testing Revenue by Country (2023-2028) & (USD Million)

Table 105. Asia-Pacific Rare Disease Genetic Testing Revenue by Type (2017-2022) & (USD Million)

Table 106. Asia-Pacific Rare Disease Genetic Testing Revenue by Type (2023-2028) & (USD Million)

Table 107. Asia-Pacific Rare Disease Genetic Testing Revenue by Application (2017-2022) & (USD Million)

Table 108. Asia-Pacific Rare Disease Genetic Testing Revenue by Application (2023-2028) & (USD Million)

Table 109. Asia-Pacific Rare Disease Genetic Testing Revenue by Region (2017-2022) & (USD Million)

Table 110. Asia-Pacific Rare Disease Genetic Testing Revenue by Region (2023-2028) & (USD Million)

Table 111. South America Rare Disease Genetic Testing Revenue by Type (2017-2022) & (USD Million)

Table 112. South America Rare Disease Genetic Testing Revenue by Type (2023-2028) & (USD Million)

Table 113. South America Rare Disease Genetic Testing Revenue by Application (2017-2022) & (USD Million)

Table 114. South America Rare Disease Genetic Testing Revenue by Application (2023-2028) & (USD Million)

Table 115. South America Rare Disease Genetic Testing Revenue by Country (2017-2022) & (USD Million)

Table 116. South America Rare Disease Genetic Testing Revenue by Country (2023-2028) & (USD Million)

Table 117. Middle East & Africa Rare Disease Genetic Testing Revenue by Type (2017-2022) & (USD Million)

Table 118. Middle East & Africa Rare Disease Genetic Testing Revenue by Type (2023-2028) & (USD Million)

Table 119. Middle East & Africa Rare Disease Genetic Testing Revenue by Application (2017-2022) & (USD Million)

Table 120. Middle East & Africa Rare Disease Genetic Testing Revenue by Application (2023-2028) & (USD Million)

Table 121. Middle East & Africa Rare Disease Genetic Testing Revenue by Country (2017-2022) & (USD Million)

Table 122. Middle East & Africa Rare Disease Genetic Testing Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Rare Disease Genetic Testing Picture

Figure 2. Global Rare Disease Genetic Testing Revenue Market Share by Type in 2021

Figure 3. Next-Generation Sequencing (NGS)

Figure 4. Array Technology

Figure 5. PCR-based Testing

Figure 6. Fluorescence in Situ Hybridization (FISH)

Figure 7. Sanger Sequencing

Figure 8. Karyotyping

Figure 9. Others

Figure 10. Rare Disease Genetic Testing Revenue Market Share by Application in 2021

Figure 11. Research Laboratories and CROs Picture

Figure 12. Diagnostic Laboratories Picture

Figure 13. Hospitals and Clinics Picture

Figure 14. Others Picture

Figure 15. Global Rare Disease Genetic Testing Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 16. Global Rare Disease Genetic Testing Revenue and Forecast (2017-2028) & (USD Million)

Figure 17. Global Rare Disease Genetic Testing Revenue Market Share by Region (2017-2028)

Figure 18. Global Rare Disease Genetic Testing Revenue Market Share by Region in 2021

Figure 19. North America Rare Disease Genetic Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Europe Rare Disease Genetic Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Asia-Pacific Rare Disease Genetic Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. South America Rare Disease Genetic Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Middle East and Africa Rare Disease Genetic Testing Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. Rare Disease Genetic Testing Market Drivers

Figure 25. Rare Disease Genetic Testing Market Restraints

Figure 26. Rare Disease Genetic Testing Market Trends

Figure 27. Quest Diagnostics Recent Developments and Future Plans

Figure 28. Centogene Recent Developments and Future Plans

Figure 29. Invitae Corporation Recent Developments and Future Plans

Figure 30. 3billion Recent Developments and Future Plans

Figure 31. Arup Laboratories Recent Developments and Future Plans

Figure 32. Eurofins Scientific Recent Developments and Future Plans

Figure 33. Strand Life Sciences Recent Developments and Future Plans

Figure 34. Ambry Genetics Recent Developments and Future Plans

Figure 35. Perkin Elmer Recent Developments and Future Plans

Figure 36. Macrogen Recent Developments and Future Plans

Figure 37. Baylor Genetics Recent Developments and Future Plans

Figure 38. Color Genomics Recent Developments and Future Plans

Figure 39. Preventiongenetics Recent Developments and Future Plans

Figure 40. Progenity Recent Developments and Future Plans

Figure 41. Coopersurgical Recent Developments and Future Plans

Figure 42. Fulgent Genetics Recent Developments and Future Plans

Figure 43. Myriad Genetics Recent Developments and Future Plans

Figure 44. LabCorp Recent Developments and Future Plans

Figure 45. Opko Health Recent Developments and Future Plans

Figure 46. Global Rare Disease Genetic Testing Revenue Share by Players in 2021

Figure 47. Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 48. Global Top 3 Players Rare Disease Genetic Testing Revenue Market Share in 2021

Figure 49. Global Top 10 Players Rare Disease Genetic Testing Revenue Market Share in 2021

Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 51. Global Rare Disease Genetic Testing Revenue Share by Type in 2021

Figure 52. Global Rare Disease Genetic Testing Market Share Forecast by Type (2023-2028)

Figure 53. Global Rare Disease Genetic Testing Revenue Share by Application in 2021

Figure 54. Global Rare Disease Genetic Testing Market Share Forecast by Application (2023-2028)

Figure 55. North America Rare Disease Genetic Testing Sales Market Share by Type (2017-2028)

Figure 56. North America Rare Disease Genetic Testing Sales Market Share by Application (2017-2028)

Figure 57. North America Rare Disease Genetic Testing Revenue Market Share by Country (2017-2028)

Figure 58. United States Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Canada Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Mexico Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Europe Rare Disease Genetic Testing Sales Market Share by Type (2017-2028)

Figure 62. Europe Rare Disease Genetic Testing Sales Market Share by Application (2017-2028)

Figure 63. Europe Rare Disease Genetic Testing Revenue Market Share by Country (2017-2028)

Figure 64. Germany Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. France Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. United Kingdom Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Russia Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Italy Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Asia-Pacific Rare Disease Genetic Testing Sales Market Share by Type (2017-2028)

Figure 70. Asia-Pacific Rare Disease Genetic Testing Sales Market Share by Application (2017-2028)

Figure 71. Asia-Pacific Rare Disease Genetic Testing Revenue Market Share by Region (2017-2028)

Figure 72. China Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Japan Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. South Korea Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. India Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Southeast Asia Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Australia Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. South America Rare Disease Genetic Testing Sales Market Share by Type (2017-2028)

Figure 79. South America Rare Disease Genetic Testing Sales Market Share by Application (2017-2028)

Figure 80. South America Rare Disease Genetic Testing Revenue Market Share by Country (2017-2028)

Figure 81. Brazil Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Argentina Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. Middle East and Africa Rare Disease Genetic Testing Sales Market Share by Type (2017-2028)

Figure 84. Middle East and Africa Rare Disease Genetic Testing Sales Market Share by Application (2017-2028)

Figure 85. Middle East and Africa Rare Disease Genetic Testing Revenue Market Share by Country (2017-2028)

Figure 86. Turkey Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 87. Saudi Arabia Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 88. UAE Rare Disease Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 89. Methodology

Figure 90. Research Process and Data Source